Sharaf, Radwa
Montesion, Meagan
Hopkins, Julia F.
Song, Jiarong
Frampton, Garrett M.
Albacker, Lee A. http://orcid.org/0000-0002-5070-1783
Article History
Received: 4 August 2021
Accepted: 11 February 2022
First Online: 26 February 2022
Declarations
:
: Approval for this study, including a waiver of informed consent and a HIPAA waiver of authorization, was obtained from the Western Institutional Review Board (Protocol No. 20152817) prior to study conduct. The Institutional Review Board granted a waiver of informed consent under 45 CFR ยง 46.116 based on review and determination that this research meets the following requirements: (i) the research involves no more than minimal risk to the subjects; (ii) the research could not practicably be carried out without the requested waiver; (iii) the waiver will not adversely affect the rights and welfare of the subjects. The work conforms to the principles of the Helsinki Declaration. Consented data that can be released is included in the paper and its supplementary files. Patients were not consented for the release of underlying sequence data.
: Not applicable.
: All authors are employees of Foundation Medicine, Inc. and are stockholders of Roche Holding AG. The authors declare no other competing interests.